EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Carboxyl Amidation of Chlorogenic Acid Improves Anti-Inflammatory Activity and Biosafety via Potent AKR1B1 Inhibition in LPS-Induced Macrophages

Faliu Yang iD, Chunmei Guang, Huan Chen, Hongwei Hou

Molecules · 2026

DOI: 10.3390/molecules31183247 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Faliu Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Life Science Academy, Beijing 102200, China. Hauptthemen laut MEDLINE: Chlorogenic Acid, Anti-Inflammatory Agents, Macrophages, Lipopolysaccharides. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Life Science Academy, Beijing Postdoctoral Research Foundation Project, Beijing Life Science Academy Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Persistent inflammation driven by excessive AKR1B1 activation contributes to the progression of multiple chronic inflammatory diseases. Natural chlorogenic acid (CGA) exhibits anti-inflammatory activity but suffers from poor membrane permeability, while its laurate ester derivative (CGL) shows clear dose-dependent cytotoxicity in macrophages. Here, we synthesized a novel chlorogenic acid amide derivative (CGAA) by selective amidation of the aliphatic carboxyl group on the quinic acid moiety of CGA, fully preserving the chiral polyphenol scaffold. Structural identity was confirmed by HSQC, HMBC, FTIR and HR-ESI-MS. CCK-8 assays demonstrated that CGAA maintained > 95% viability of RAW264.7 cells at 100 μM, displaying markedly superior cellular safety relative to CGL. In LPS-stimulated RAW264.7 macrophages, CGAA dose-dependently suppressed NO, TNF-α and IL-6 production and exhibited stronger antioxidant activity than both CGA and CGL. Temperature-gradient CETSA, DARTS and enzymatic assays established direct binding and potent inhibition of AKR1B1 by CGAA (IC50 = 7.85 μM). Molecular docking revealed that the newly introduced amide forms an additional hydrogen bond with ILE-260, enhancing ligand–target affinity. This carboxyl-amidation strategy simultaneously improves the cellular safety and AKR1B1 inhibitory potency of CGA, providing a rational approach for developing low-toxicity polyphenol-based anti-inflammatory leads.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chlorogenic AcidAnti-Inflammatory AgentsMacrophagesLipopolysaccharidesAldehyde ReductaseAmidesAldo-Keto ReductasesAnimalsMiceMolecular Docking SimulationRAW 264.7 CellsCell Survival

Stichwörter der Autor:innen

AKR1B1 inhibitionRAW264.7 macrophagesanti-inflammationcarboxyl-amidationcellular safetychlorogenic acid amidemolecular docking

Substanzen

Chlorogenic AcidAnti-Inflammatory AgentsLipopolysaccharidesAldehyde ReductaseAmidesAldo-Keto Reductases

Autor:innen und Institutionen

  • Beijing Life Science Academy, Beijing 102200, China.

ORCID-Profile: Faliu Yang

Förderung

  • Beijing Life Science Academy
  • Beijing Postdoctoral Research Foundation Project
  • Beijing Life Science Academy Research Project

Zitieren

APA

Yang, F., Guang, C., Chen, H., & Hou, H. (2026). Carboxyl Amidation of Chlorogenic Acid Improves Anti-Inflammatory Activity and Biosafety via Potent AKR1B1 Inhibition in LPS-Induced Macrophages. Molecules. https://doi.org/10.3390/molecules31183247

Vancouver

Yang F, Guang C, Chen H, Hou H. Carboxyl Amidation of Chlorogenic Acid Improves Anti-Inflammatory Activity and Biosafety via Potent AKR1B1 Inhibition in LPS-Induced Macrophages. Molecules. 2026. doi:10.3390/molecules31183247

BibTeX
@article{Yang2026,
  author = {Yang, Faliu and Guang, Chunmei and Chen, Huan and Hou, Hongwei},
  title = {Carboxyl Amidation of Chlorogenic Acid Improves Anti-Inflammatory Activity and Biosafety via Potent AKR1B1 Inhibition in LPS-Induced Macrophages},
  journal = {Molecules},
  year = {2026},
  doi = {10.3390/molecules31183247}
}
Kostenlos starten →